Site records / India / FEI 3004462816
Sbl (india) Private LimitedJaipur
FDA-registered drug establishment in Jaipur: manufacture. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.
- Inspections posted
- None
- Last inspection
- None posted
- Warning letters to this FEI
- 0
- Import alerts at this address
- 0 of 1 under the name
- US border refusals, 2 years
- 8
The full record.
Every fact sourced.
- A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
- Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
- Warning-letter violations, numbered and labelled
- Import-alert history rebuilt from the archive, each listing checked against this address
- Border refusals by product, and the company's other sites, each graded
- A hash of every source read, so the PDF can be checked against the record
On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.
FDA has posted no classified inspection for this site, so its dossier carries no grade. It holds the rest of the record: registration, import alerts, border refusals and the company's other sites.
PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.
By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.
Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan
Inspections
FDA has posted no inspection of this FEI. That is an absence of record, not a clean one.
Warning letters and compliance actions
No FDA compliance action recorded against this FEI or letter to its name.
Import alerts in force
Import-alert pages list a firm name and an address, never an FEI. Each listing under this firm's name is shown with the address FDA published and whether it is this site's.
- 22 Dec 2023Import alert 66-41 · Published address is not this site SourceDetention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.Published address: Sbl House , 2, Commercial Complex, Shrestha Vihar , East Delhi, Delhi INDIA
Registration
- FEI
- 3004462816
- DUNS
- 876818924
- Registered as
- Sbl (india) Private Limited
- Registrant
- Bakson Drugs and Pharmaceuticals Private Limited
- Address
- 533, Sitapura Industrial Area, Jaipur, 302022, India (IND)
- Operations
- MANUFACTURE
- Registration expires
- 31 Dec 2026
Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.